Plasmapheresis in the Treatment of Neurologic Disorders in Bangladesh: A Review Update

Authors

  • Sharmin Jahan Assistant Professor, Department of Endocrinology, Bangabandhu Sheikh Mujib Medical University, Dhaka
  • Mohammad Enayet Hussain Assistant Professor, Department of Neurophysiology, National Institute of Neurosciences & Hospital, Dhaka
  • Md Badrul Alam Professor, Department of Neurology, National Institute of Neurosciences & Hospital, Dhaka
  • Quazi Deen Mohammad Professor, Department of Neurology, National Institute of Neurosciences & Hospital, Dhaka

DOI:

https://doi.org/10.3329/jninb.v1i2.29852

Keywords:

Plasmapheresis, neurologic disorders, immune-mediated, IVIg

Abstract

Plasmapheresis is a very effective modality of treatment for many of the immune-mediated neurological disorders. It is a relatively new concept in the context of our country. Although it was previously done in one or two of the private hospitals but the expense was beyond the affordability of m59ost of our patients. Since its inception on September, 2012 the National Institute of Neurosciences & Hospital (NINS) has made some major advancement in patient management. Initiation of plasmapheresis at an affordable cost is one such example. In this article we intend to share our experience of the few cases who have received this treatment.

Journal of National Institute of Neurosciences Bangladesh, 2015;1(2): 62-64

Downloads

Download data is not yet available.
Abstract
1312
PDF
723

References

Wallace, D. J. Apharesis for lupus erythematosus. Lupus 1999; 8:

180

Drew, MJ. Plasmapheresis in the dysproteinemias"Therapeutic

apheresis. ?official journal of the International Society for Apheresis and the Japanese Society for Apheresis .2002; 6 (1): 4552

Osterman PO, Lundemo G, Pirskanen R, Fagius J, Pihlstedt P, Siden A. Beneficial effects of plasma exchange in acute inflammatory polyradiculoneuropathy. Lancet 1984;2:1296-1298

Guillain-Barre Study Group. Plasmapheresis and acute Guillain-Barre syndrome. Neurology 1985; 35:1096-1104

Dyck PJ, Daube J, O'Brien P, et al. Plasma exchange in chronic

inflammatory demyelinating polyradiculoneuropathy. N Engl J Med 1986; 314:461-465

Mori M, Kuwabara S, Fukutake T, Hattori T. Plasmapheresis and Miller Fisher syndrome: analysis of 50 consecutive cases. J Neurolog Neurosur Psychiatry 2002;72 (5): 68

Batocchi AP, Evoli A, Di-Schino C, Tonali P. Therapeutic apheresis in

myasthenia gravis". Therapeutic apheresis : official journal of the

International Society for Apheresis and the Japanese Society for

Apheresis.2000; 4 (4): 275

Dau PC, Lindstrom JM, Cassel CK, Denys EH, Shev EE, Spitler LE.

Plasmapheresis and immunosuppressive drug therapy in myasthenia

gravis. N Engl J Med 1977;297:1134-1140

Downloads

Published

2017-04-06

How to Cite

Jahan, S., Hussain, M. E., Alam, M. B., & Mohammad, Q. D. (2017). Plasmapheresis in the Treatment of Neurologic Disorders in Bangladesh: A Review Update. Journal of National Institute of Neurosciences Bangladesh, 1(2), 62–64. https://doi.org/10.3329/jninb.v1i2.29852

Issue

Section

Review Articles